Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:122-127

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, P. B.
Right arrow Articles by Topol, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, P. B.
Right arrow Articles by Topol, E. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Hazardous Substances DB
*HEPARIN

(Circulation. 1997;96:122-127.)
© 1997 American Heart Association, Inc.


Articles

Impact of an Aggressive Invasive Catheterization and Revascularization Strategy on Mortality in Patients With Cardiogenic Shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial

An Observational Study

Peter B. Berger, MD; David R. Holmes, Jr, MS; Amanda L. Stebbins, MD; Eric R. Bates, MD; Robert M. Califf, MD; Eric J. Topol, MD; ; for the GUSTO-I Investigators

From the Division of Cardiovascular Diseases (P.B.B., D.R.H.), Mayo Clinic, Rochester, Minn; Division of Cardiology (A.L.S., R.M.C.), Duke Clinical Research Institute, Durham, NC; Division of Cardiology (E.R.B.), University of Michigan (Ann Arbor); and Department of Cardiology (E.J.T.), Cleveland Clinic, Cleveland, Ohio.

Correspondence to Peter B. Berger, MD, Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic, Rochester, MN 55905. E-mail berger.peter{at}mayo.edu

Background Although retrospective analyses have revealed an association between survival and coronary angiography and angioplasty in patients with acute myocardial infarction complicated by cardiogenic shock, the degree to which bias in the selection of patients to undergo these procedures contributes to this observation remains unclear.

Methods and Results We studied 2200 patients in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial with acute myocardial infarction complicated by cardiogenic shock (systolic blood pressure <90 mm Hg for >=1 hour) who survived >=1 hour after the onset of shock to determine the influence of an aggressive strategy of early angiography (within 24 hours of shock onset) and coronary angioplasty or bypass surgery, if appropriate, on survival. Revascularization was not protocol mandated but was selected by the attending physicians. Shock was present on admission in 11% and developed after admission in 89% of shock patients. The 30-day mortality was 38% in the 406 patients who underwent early angiography and were referred within 24 hours for angioplasty (n=175), bypass surgery (n=36), angioplasty and bypass surgery (n=22), or neither (late or no revascularization, n=173) compared with 62% in the 1794 patients who did not (P=.0001). However, there were important differences in the baseline characteristics of the two groups, including younger age (63 versus 68 years, P=.0001), less prior infarction (19% versus 27%, P=.001), and a shorter time to thrombolytic therapy (2.9 versus 3.2 hours, P=.0001) in patients treated with an aggressive strategy. Using multivariate logistic regression analysis to adjust for differences in baseline characteristics, an aggressive strategy was independently associated with reduced 30-day mortality (odds ratio, 0.43 [confidence interval, 0.34 to 0.54], P=.0001).

Conclusions An aggressive strategy of early angiography (and revascularization when appropriate) is associated with a reduction in mortality in patients with acute myocardial infarction and cardiogenic shock who receive thrombolytic therapy.


Key Words: angiography • angioplasty • infarction • reperfusion • shock




This article has been cited by other articles:


Home page
CirculationHome page
R. J. Goldberg, F. A. Spencer, J. M. Gore, D. Lessard, and J. Yarzebski
Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective
Circulation, March 10, 2009; 119(9): 1211 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
J. S. Hochman and A. H. Skolnick
Contemporary Management of Cardiogenic Shock: Age Is Opportunity
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 153 - 155.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
Developed in Collaboration With the American Socie, WRITING COMMITTEE MEMBERS, L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Anesth. Analg., March 1, 2008; 106(3): 685 - 712.
[Full Text] [PDF]


Home page
CirculationHome page
R. H. Mehta, J. D. Grab, S. M. O'Brien, D. D. Glower, C. K. Haan, J. S. Gammie, E. D. Peterson, and on Behalf of the Society of Thoracic Surgeons Nati
Clinical Characteristics and In-Hospital Outcomes of Patients With Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Insights From the Society of Thoracic Surgeons National Cardiac Database
Circulation, February 19, 2008; 117(7): 876 - 885.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598.
[Full Text]


Home page
J Am Coll CardiolHome page
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1707 - 1732.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
J. Am. Coll. Cardiol., October 23, 2007; 50(17): e159 - e242.
[Full Text] [PDF]


Home page
JAMAHome page
The TRIUMPH Investigators
Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock: The TRIUMPH Randomized Controlled Trial
JAMA, April 18, 2007; 297(15): 1657 - 1666.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. V. Jeger, S. M. Harkness, K. Ramanathan, C. E. Buller, M. E. Pfisterer, L. A. Sleeper, J. S. Hochman, and for the SHOCK Investigators
Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry
Eur. Heart J., March 2, 2006; 27(6): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
W. J. Cantor, F. Brunet, C. P. Ziegler, A. Kiss, and L. J. Morrison
Immediate angioplasty after thrombolysis: a systematic review
Can. Med. Assoc. J., December 6, 2005; 173(12): 1473 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 5: Acute Coronary Syndromes
Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. C. Dang, V. K. Topkara, M. Leacche, R. John, J. G. Byrne, and Y. Naka
Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. El-Banayosy, D. Cobaugh, A. Zittermann, L. Kitzner, L. Arusoglu, M. Morshuis, H. Milting, G. Tenderich, and R. Koerfer
A Multidisciplinary Network To Save the Lives of Severe, Persistent Cardiogenic Shock Patients
Ann. Thorac. Surg., August 1, 2005; 80(2): 543 - 547.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K. P. Bouki, G. Pavlakis, and E. Papasteriadis
Management of Cardiogenic Shock Due to Acute Coronary Syndromes
Angiology, March 1, 2005; 56(2): 123 - 130.
[Abstract] [PDF]


Home page
HeartHome page
A G C Sutton, P Finn, J A Hall, A A Harcombe, R A Wright, and M A de Belder
Predictors of outcome after percutaneous treatment for cardiogenic shock
Heart, March 1, 2005; 91(3): 339 - 344.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Kashani, R. P. Giugliano, E. M. Antman, D. A. Morrow, C. M. Gibson, S. A. Murphy, and E. Braunwald
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction
Eur. Heart J., October 1, 2004; 25(19): 1702 - 1710.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. J. Camm, C. M. Pratt, P. J. Schwartz, H. R. Al-Khalidi, M. J. Spyt, M. J. Holroyde, R. Karam, E. H. Sonnenblick, J. M.G. Brum, and on Behalf of the AzimiLide post Infarct surVival E
Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification
Circulation, March 2, 2004; 109(8): 990 - 996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. W. Chen, J. G. Canto, L. S. Parsons, E. D. Peterson, K. A. Littrell, N. R. Every, C. M. Gibson, J. S. Hochman, E. M. Ohman, M. Cheeks, et al.
Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Circulation, August 26, 2003; 108(8): 951 - 957.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Ducas and E. D Grech
Percutaneous coronary intervention: cardiogenic shock
BMJ, June 25, 2003; 326(7404): 1450 - 1452.
[Full Text] [PDF]


Home page
Eur Heart JHome page
V. Dzavik, L.A. Sleeper, T.P. Cocke, M. Moscucci, J. Saucedo, S. Hosat, X. Jiang, J. Slater, T. LeJemtel, J.S. Hochman, et al.
Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry
Eur. Heart J., May 1, 2003; 24(9): 828 - 837.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D.R Holmes
The final common pathway
Eur. Heart J., February 1, 2003; 24(3): 214 - 216.
[Full Text] [PDF]


Home page
ChestHome page
H.-K. Yip, C.-J. Wu, M. Fu, K.-H. Yeh, T.-H. Yu, W.-C. Hung, and M.-C. Chen
Clinical Features and Outcome of Patients With Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction Resulting From Left Circumflex Artery Occlusion
Chest, December 1, 2002; 122(6): 2068 - 2074.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
V. Menon and J. S Hochman
MANAGEMENT OF CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION
Heart, December 1, 2002; 88(5): 531 - 537.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
K P Balachandran, J Miller, A C H Pell, B D Vallance, and K G Oldroyd
Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital
Postgrad. Med. J., June 1, 2002; 78(920): 330 - 334.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J Llevadot, R.P Giugliano, E.M Antman, R.G Wilcox, E.P Gurfinkel, T Henry, C.H McCabe, A Charlesworth, S Thompson, J.C Nicolau, et al.
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction
Eur. Heart J., November 2, 2001; 22(22): 2104 - 2115.
[Abstract] [PDF]


Home page
HeartHome page
I M Barbash, S Behar, A Battler, D Hasdai, V Boyko, S Gottlieb, and J Leor
Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities
Heart, August 1, 2001; 86(2): 145 - 149.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C.H. Davies
Revascularization for cardiogenic shock
QJM, February 1, 2001; 94(2): 57 - 67.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. C. Wong, T. Sanborn, L. A. Sleeper, J. G. Webb, R. Pilchik, D. Hart, S. Mejnartowicz, T. A. Antonelli, R. Lange, J. K. French, et al.
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. M. Shindler, S. T. Palmeri, T. A. Antonelli, L. A. Sleeper, J. Boland, T. P. Cocke, J. S. Hochman, and for the SHOCK Investigators
Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1097 - 1103.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S G Williams, D J Wright, and L B Tan
Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice
Heart, June 1, 2000; 83(6): 621 - 626.
[Full Text]


Home page
CirculationHome page
N. S. Kleiman, A. M. Lincoff, G. C. Flaker, K. S. Pieper, R. G. Wilcox, L. G. Berdan, T. J. Lorenz, D. V. Cokkinos, M. L. Simoons, E. Boersma, et al.
Early Percutaneous Coronary Intervention, Platelet Inhibition With Eptifibatide, and Clinical Outcomes in Patients With Acute Coronary Syndromes
Circulation, February 22, 2000; 101(7): 751 - 757.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hasdai, R. M. Califf, T. D. Thompson, J. S. Hochman, E. M. Ohman, M. Pfisterer, E. R. Bates, A. Vahanian, P. W. Armstrong, D. A. Criger, et al.
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 136 - 143.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. S. Hochman, L. A. Sleeper, J. G. Webb, T. A. Sanborn, H. D. White, J. D. Talley, C. E. Buller, A. K. Jacobs, J. N. Slater, J. Col, et al.
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
N. Engl. J. Med., August 26, 1999; 341(9): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. M. Hollenberg, C. J. Kavinsky, and J. E. Parrillo
Cardiogenic Shock
Ann Intern Med, July 6, 1999; 131(1): 47 - 59.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. J. Goldberg, N. A. Samad, J. Yarzebski, J. Gurwitz, C. Bigelow, and J. M. Gore
Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction
N. Engl. J. Med., April 15, 1999; 340(15): 1162 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. P. Wharton Jr., N. S. McNamara, F. A. Fedele, M. I. Jacobs, A. R. Gladstone, and E. J. Funk
Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Berger, R. H. Tuttle, D. R. Holmes Jr, E. J. Topol, P. E. Aylward, J. H. Horgan, and R. M. Califf
One-Year Survival Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock, and its Relation to Early Revascularization : Results From the GUSTO-I Trial
Circulation, February 23, 1999; 99(7): 873 - 878.
[Abstract] [Full Text] [PDF]


Home page
JWatch Emergency Med.Home page
MI with Cardiogenic Shock: Invasive Treatment Saves Lives
Journal Watch Emergency Medicine, September 1, 1997; 1997(901): 11 - 11.
[Full Text]


Home page
JWatch GeneralHome page
AGGRESSIVE MANAGEMENT FOR POST-MI CARDIOGENIC SHOCK APPEARS BENEFICIAL
Journal Watch (General), July 29, 1997; 1997(729): 4 - 4.
[Full Text]